News Field Trip becomes latest psychedelic firm to go public Psychedelic therapy company Field Trip Psychedelics has announced that it will soon join the growing list of psychedelic companies going public.
News Protego's $130m for amyloidosis drug, and other financings Our latest crop of biotech financings has nine-figure rounds for Protego and Triana, with Excelsior Sciences and SciNeuro also raising new funds.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.